Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
17 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-major-clinical-milestones-across-multiple-development-programs-302431503.html
28 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-fda-acceptance-of-new-drug-application-for-sl1009-for-treatment-of-pyruvate-dehydrogenase-complex-deficiency-302361297.html
03 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-submission-of-new-drug-application-nda-to-the-us-fda-for-sl1009-302320045.html
30 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-positive-topline-results-from-the-sl-1002-raise-limb-spasticity-trial-302290497.html
19 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-completion-of-enrollment-in-both-the-phase-ii-compass-osteoarthritis-knee-pain-trial-and-the-phase-ii-raise-limb-spasticity-trial-301930918.html
04 Oct 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-enrollment-achievement-in-pivotal-phase-3-trial-for-rare-mitochondrial-disease--pyruvate-dehydrogenase-complex-deficiency-pdcd-301638162.html
ABOUT THIS PAGE